Much of the medical community, including the World Health Organization, warns that during the COVID-19 pandemic erroneous or incomplete information regarding vaccines for the deadly virus has pervaded the public’s purview, and, consequently contributed to much of the population declining or pausing to get vaccinated. A documentary addresses this public perception by tracing the origins of vaccinations, explaining the science behind it and presenting compelling testimonials. Vaccination from the Misinformation Virus will be aired nationally beginning in July on PBS TV and other outlets.
Watch the trailer of the upcoming documentary, created by Emmy Award winning producer Chris Schueler.
Become a Ready Reserve Officer in the U.S. Public Health Service
The Ready Reserve Corps offers a unique opportunity for its officers to serve their local community as well as their country in times of public health emergencies or in underserved areas. This is an excellent opportunity for pharmacist graduates who are interested in public service but are not able to commit to be a full-time officer.
The COVID-19 Prevention Network (CoVPN) was formed by the National Institute of Allergy and Infectious Diseases (NIAID) at the US National Institutes of Health (NIH) to respond to the global pandemic. Using the infectious disease expertise of their existing research networks and global partners, NIAID has directed the networks to address the pressing need for vaccines and monoclonal antibodies (mAbs) against SARS-CoV-2.
The network is seeking the assistance of pharmacists and pharmacy personnel to inform the public of the opportunity to participate in the clinical trials. More information and the link to volunteer can be found at the COVID-19 Prevent Network website.
There are materials available to pharmacists that can be used to share with patients, communities, family and friends. A special referral code (RXRX) has been created for individuals to include when signing up that identifies pharmacy as the source of referral and demonstrate pharmacy’s impact.
The development and release of effective vaccines against COVID-19 is dependent upon recruiting sufficient numbers of individuals to participate in the vaccine clinical trials, especially individuals within these targeted demographics:
People with underlying medical conditions
People with greater chances of exposure at their job
People who live or work in elder-care facilities
People over age 65
People who work in jails or prisons
People from racial and ethnic groups that have been impacted in greater numbers by the epidemic, such as African Americans, Latinx, and Native Americans
Individuals interested in volunteering complete a short online survey that includes some personal questions and entry into a registry. The purpose of the screening registry is to create a list of potential volunteers who want to take part in current or future COVID-19 prevention clinical trials. Individuals must be 18 years or older to participate. Participation is voluntary.
COVID-19 prevention study participants will be compensated for their time. COVID-19 prevention study participants CANNOT get infected with SARS-CoV-2 or get COVID-19 illness from the study vaccine.
After careful consideration for the safety of our training class participants, instructors, and staff, the American College of Apothecaries resumed in-person training classes on June 4. ACA followed local public health guidelines to develop the following protocols.
Our top priority is providing the best training opportunities for pharmacy professionals in the safest environment for employees, instructors, participants, and the community.
Our safety protocols include:
Daily health screening upon entrance to facility for all class participants and staff
Limiting visitors to facility and lowering class size
Allowing staff to telework and informing staff not to come to work if sick
Enforcing six-foot distancing for all individuals throughout facility
Dedicated workspaces for class participants during compounding training courses, including classroom and lab areas
Providing masks to every individual
Providing hand sanitizer and disinfectant wipes to all visitors, class participants and staff at facility entrance, in bathrooms, breakroom, training room, and labs
Offices, bathrooms, breakroom, and lab are cleaned and disinfected daily
Additional measures will be taken throughout the facility to prevent unnecessary contact between individuals
In an unprecedented public-private partnership, PPP Loans will be funded through SBA-Approved lenders. The U.S. Treasury has released guidance on the PPP loan program, but some business owners may be wondering how staffing decisions can impact loan forgiveness. Hear from Frier Levitt’s, Co-Founding Partner, Daniel B Frier, Esq. who provides the most current information on:
Understanding the concept of how the loan is forgiven under the CARES Act
How staffing changes may impact loan forgiveness
How compensation changes may impact loan forgiveness
Evidence on potential transmission and treatment of COVID-19 is evolving rapidly.
Join the American Public Health Association and the National Academy of Medicine for a free webinar to hear from experts on emerging data.
FREE Webinar #3: Emerging Evidence on COVID-19 Spread and Treatment
Hydroxychloroquine & Its Potential Role in COVID-19 Treatment: A Review for Pharmacists
Thursday, April 9, 2020
This webinar will educate pharmacists on information about hydroxychloroquine (including ADRs, DIs), as well as provide a brief review of information from trials so that pharmacists feel more confident in understanding and answering questions about its current place in therapy.
This program is approved for 1.5 contact hours (0.15 CEUs) of continuing education credit for pharmacists and technicians.
Effective March 25, 2020, our office building will be closed; all staff will be working from home during our regular business hours, Monday – Thursday, 8:00 am-5:00 pm and 8:00 am-noon on Friday. We will not be answering the phones, but will be responding to emails using the contact form.
The COVID-19 Prevention Network (CoVPN) is seeking the assistance of pharmacists and pharmacy personnel to inform the public of the opportunity to participate in the clinical trials for vaccines and monoclonal antibodies (mAbs) against SARS-CoV-2. Learn more…
VaccineFinder and MedFinder now offer flexible methods for pharmacies to update their vaccine and antiviral drug supply through both automated and manual reporting options. Learn more…
US Department of Health & Human Services
As the most accessible and frequently visited members of the healthcare team, pharmacists will play a vital role in America’s COVID-19 publc health response with the ability to order and administer testing for their patients.
The ACA supports the work done by pharmacy organizations to remove the barriers to Pharmacists so that we can provide our communities with needed COVID-19 tests and referrals when necessary.
CDC recently released additional guidance documents of interest to pharmacists. Note as circumstances change this information will be updated by CDC:
CDC Pharmacy Partnership Programs for COVID-19 Vaccination chart explains the currently available program(s) for pharmacy engagement and how the federal and state processes work together. The CDC is providing jurisdictions an opportunity to transfer vaccine allocation to federal pharmacy partners to help vaccinate target populations against COVID-19 before the Federal Retail Pharmacy Program launches nationwide. This graphic captures some of the key elements to help pharmacists understand the differences and operations of the programs.
COCA prepares clinicians to respond to emerging health threats and public health emergencies by communicating relevant, timely information related to disease outbreaks, disasters, terrorism events, and other health alerts.
UPDATED: December 15, 2020
USP continues to provide resources in response to the COVID-19 pandemic. Here is the link to the updated document as of December 15, 2020 which includes added considerations for preparing conventionally manufactured COVID-19 vaccines which have received Emergency Use Authorization from the FDA.
Any technical questions on these and other compounding resources should be sent to CompoundingSL@usp.org.
In light of the rapidly evolving COVID-19 pandemic, the demand for garbing and personal protective equipment (PPE) and alcohol-based hand sanitizer is expected to outpace available supply. During this pandemic, USP supports State Boards and other regulators using risk-based enforcement discretion related to the implementation of USP compounding standards and the compounding of alcohol-based hand sanitizers for consumer use.
The USP Compounding Expert Committee developed the following informational resources that may be of assistance during this public health emergency:
From the FDA: Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency
UPDATED: March 14, 2020
Due to the Coronavirus Disease 2019 (COVID-19) pandemic, the Food and Drug Administration (FDA or Agency) has received a number of queries concerning compounding of alcohol-based hand sanitizers. Read or download the guidance here: https://www.fda.gov/media/136118/download
Joint ACA | ACVP | PPSI Statement on COVID-19
UPDATED: March 12, 2020
We understand and support the difficult decision made yesterday by the American Pharmacists Association to cancel their upcoming Annual Meeting and Expo. This cancellation includes all related conference activites, including the PPSI Public Health Town Hall Breakfast scheduled for Sunday, March 22. We are currently evaluating our options for rescheduling this event at a later date.
Registration for the ACVP Veterinary Pharmacy Conference, June 25-27, in Raleigh, North Carolina is still open. We are monitoring the situation and exploring other options. We anticipate making a decision regarding the feasibility of hosting a live conference by mid-April.
March 10, 2020
At the American College of Apothecaries, American College of Veterinary Pharmacists, and Pharmacists Planning Services, Inc., public health and safety is our top priority.
While we are operating as usual, we are also working on contingency plans to be prepared for changing circumstances. We are actively following the Centers for Disease Control (CDC) and local state departments of health as well as local public health authorities so we can respond quickly to any shifts in their recommendations.
What are ACA , ACVP, and PPSI doing in response to COVID-19?
Our organizations are monitoring the situation closely.
As of today, our plan is to still hold our upcoming events as scheduled, including compounding training courses at the National Training Laboratory in Bartlett, Tennessee and the ACVP Veterinary Pharmacy Conference in Raleigh, North Carolina.
Due to the evolving nature of this situation, cancellations may have to be made with short notice, for instance in the case of a public health directive. We will do our best to contact all those affected as quickly as possible.
What steps can pharmacists take to prevent the spread of COVID-19?
Recommend to your patients and staff to follow all of the steps recommended by the CDC. The same simple steps that prevent the spread of ordinary flu viruses work against COVID-19 and other illnesses:
Wash your hands often with soap and water for at least 20 seconds. Use an alcohol-based hand sanitizer if soap and water are not available.
Cough into a tissue or your elbow (not your hand). Then throw the tissue away and wash hands.
Avoid touching your eyes, nose, or mouth with unwashed hands.
Avoid contact with people who are sick.
Stay home when you are sick, with a temperature above 100.0 F (38.7 C) or do not feel well, appear weak or ill.
Consult your health care provider if you have special health conditions that put you at increased risk.
Be a Source of Comfort and Calm for the Public
The CDC has developed a helpful resource for Healthcare Professionals that covers clinical features, infection control, and guidances for evaluating and reporting persons under investigation (PUI).
Additional information and resources about the Covid-19:
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.